Genomics
1 Transcripts
| WormMine ID | Sequence Name | Length (nt) | Chromosome Location |
|---|---|---|---|
| Transcript:H09I01.4 | H09I01.4 |
88
![]() |
IV: 8253090-8253177 |
Other
9 Allele
| Public Name |
|---|
| gk964278 |
| gk964500 |
| gk962765 |
| gk963722 |
| gk963417 |
| gk762106 |
| WBVar02121210 |
| WBVar02057935 |
| gk793036 |
1 Chromosome Location
|
Feature . Primary Identifier |
Start | End | Strand |
|---|---|---|---|
| WBGene00195811 | 8253090 | 8253177 | -1 |
1 Downstream Intergenic Region
| WormBase ID | Name | Sequence Name | Length (nt) | Chromosome Location | Organism |
|---|---|---|---|---|---|
| intergenic_region_chrIV_8246534..8253089 | 6556 | IV: 8246534-8253089 | Caenorhabditis elegans |
2 Expression Clusters
| Regulated By Treatment | Description | Algorithm | Primary Identifier |
|---|---|---|---|
| Transcripts that showed signifcantly increased expression in pabp-2(RNAi) animals comparing to in N2 animals injected with empty vector at L1 larva stage and collected at L4 larva stage. | FDR < 0.05, fold change > 2 | WBPaper00067368:pabp-2(RNAi)_upregulated_N2 | |
| Transcripts that showed significantly decreased expression in animals after 24 hour exposure to 100ug per ml silica nanoparticles (SiNPs). | The random variance model (RVM)t-test was applied toidentify differentially expressed mRNAs and miRNAsbetween the SiNPs-treated group and the control group. P-value <0.05 and fold change (FC) >1.5 were considered as the threshold screening between the SiNP-treated groupand the control group. | WBPaper00060100:SiNP_downregulated_mRNA |
1 Upstream Intergenic Region
| WormBase ID | Name | Sequence Name | Length (nt) | Chromosome Location | Organism |
|---|---|---|---|---|---|
| intergenic_region_chrIV_8253178..8253855 | 678 | IV: 8253178-8253855 | Caenorhabditis elegans |




